Skip to Main Content

Paper Details

Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy.
Clin Cancer Res
10
2023
1q, BRAFV600E, BRAFV600E tumors, BRAFV600E/1q-quiet tumors, ER, ER tumors, MAPK, Metastatic Thyroid Cancers, NR, PI3K, RAF, RAI, RAS, RTK fusions, Radioactive Iodine, class 2 BRAF, mRNA, metastatic thyroid cancer, radioiodine, thyroid cancers, tumor
Author NameAffiliation
Fengshen KuoMemorial Sloan Kettering Cancer Center
Nicholas D SocciMemorial Sloan Kettering Cancer Center
Alan L HoMemorial Sloan Kettering Cancer Center
Luc G T MorrisMemorial Sloan Kettering Cancer Center
  • 1 - 4

Datasets

Release 1.2